HALO

NASDAQStock

Halozyme Therapeutics, Inc.

$63.98-2.52 (-3.78%)

52-Week Range

$47.91
$81.23

Key Stats

Market Cap

7.6B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

Volume

1.2M

Avg Volume

1.7M

Performance

1M

-20.06%

3M

+0.17%

6M

-16.73%

YTD

-9.60%

1Y

+4.09%

3Y

+51.33%

5Y

+45.88%

Price Chart

ETF Exposure

HALO is held by 190 ETFs

ETFFund NameWeight
RECSColumbia Research Enhanced Core ETF0.01%
SPTMState Street SPDR Portfolio S&P 1500 Composite Stock Market ETF0.01%
GUSAGoldman Sachs MarketBeta US 1000 Equity ETF0.01%
IWBiShares Russell 1000 ETF0.01%
IWViShares Russell 3000 ETF0.01%
IYYiShares Dow Jones U.S. ETF0.01%
SCHKSchwab 1000 Index ETF0.01%
VONEVanguard Russell 1000 ETF0.01%
VTHRVanguard Russell 3000 ETF0.01%
VTIVanguard Total Stock Market ETF0.01%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.01%
SCHBSchwab U.S. Broad Market ETF0.01%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.01%
JHMLJohn Hancock Investments - Multifactor Large Cap ETF0.01%
VTVanguard Total World Stock ETF0.01%
VLUState Street SPDR S&P 1500 Value Tilt ETF0.01%
FNDBSchwab Fundamental U.S. Broad Market Index ETF0.01%
AFTYPacer CSOP FTSE China A50 ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
AOAiShares Core 80/20 Aggressive Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
IALTiShares Systematic Alternatives Active ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
AOMiShares Core 40/60 Moderate Allocation ETF0.00%
AORiShares Core 60/40 Balanced Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
IRTRiShares LifePath Retirement ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
AOKiShares Core 30/70 Conservative Allocation ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
IQSMNYLI Candriam U.S. Mid Cap Equity ETF0.00%
LRNDNYLI U.S. Large Cap R&D Leaders ETF0.00%
THROiShares U.S. Thematic Rotation Active ETF0.00%
PreviousPage 4 of 4

About HALO ETF Exposure

Halozyme Therapeutics, Inc. (HALO) is held by 190 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.6B, HALO is a widely held institutional stock. The stock currently trades at $63.98. Investors can gain exposure to HALO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold HALO, sorted by portfolio weight.